Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer

Clinical trial NCT02964559 · COMPLETED

Trial details

NCT number: NCT02964559
Sponsor: Emory University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Skin Carcinoma Skin Squamous Cell Carcinoma

Start date: 2017-01-27
Primary completion: 2021-05-18
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.